[go: up one dir, main page]

SE9403846D0 - Small particle formation - Google Patents

Small particle formation

Info

Publication number
SE9403846D0
SE9403846D0 SE9403846A SE9403846A SE9403846D0 SE 9403846 D0 SE9403846 D0 SE 9403846D0 SE 9403846 A SE9403846 A SE 9403846A SE 9403846 A SE9403846 A SE 9403846A SE 9403846 D0 SE9403846 D0 SE 9403846D0
Authority
SE
Sweden
Prior art keywords
pct
date
small particle
particle formation
sec
Prior art date
Application number
SE9403846A
Other languages
English (en)
Swedish (sv)
Inventor
Sylvan Frank
Jan-Erik Loefroth
Levon Bostanian
Original Assignee
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State Res Found filed Critical Univ Ohio State Res Found
Priority to SE9403846A priority Critical patent/SE9403846D0/xx
Publication of SE9403846D0 publication Critical patent/SE9403846D0/xx
Priority to EP95938091A priority patent/EP0788350B1/fr
Priority to KR1019970703072A priority patent/KR970706799A/ko
Priority to BR9509720A priority patent/BR9509720A/pt
Priority to PT95938091T priority patent/PT788350E/pt
Priority to AT95938091T priority patent/ATE213625T1/de
Priority to JP51597096A priority patent/JP4098827B2/ja
Priority to DE69525639T priority patent/DE69525639T2/de
Priority to CZ971295A priority patent/CZ129597A3/cs
Priority to DK95938091T priority patent/DK0788350T3/da
Priority to PCT/SE1995/001302 priority patent/WO1996014833A1/fr
Priority to ES95938091T priority patent/ES2173204T3/es
Priority to CN95196084A priority patent/CN1165478A/zh
Priority to HU9800181A priority patent/HUT77629A/hu
Priority to SK559-97A priority patent/SK55997A3/sk
Priority to US08/553,460 priority patent/US5780062A/en
Priority to PL95320425A priority patent/PL320425A1/xx
Priority to EE9700214A priority patent/EE9700214A/xx
Priority to AU38851/95A priority patent/AU700644B2/en
Priority to NZ295497A priority patent/NZ295497A/en
Priority to CA002203512A priority patent/CA2203512A1/fr
Priority to IL11587895A priority patent/IL115878A0/xx
Priority to ZA959386A priority patent/ZA959386B/xx
Priority to TR95/01400A priority patent/TR199501400A2/xx
Priority to IS4467A priority patent/IS4467A/is
Priority to NO971986A priority patent/NO971986L/no
Priority to FI971947A priority patent/FI118511B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Confectionery (AREA)
  • Soft Magnetic Materials (AREA)
  • Surgical Instruments (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Steroid Compounds (AREA)
SE9403846A 1994-11-09 1994-11-09 Small particle formation SE9403846D0 (sv)

Priority Applications (27)

Application Number Priority Date Filing Date Title
SE9403846A SE9403846D0 (sv) 1994-11-09 1994-11-09 Small particle formation
CA002203512A CA2203512A1 (fr) 1994-11-09 1995-11-03 Formation de petites particules
CN95196084A CN1165478A (zh) 1994-11-09 1995-11-03 微丸的形成
SK559-97A SK55997A3 (en) 1994-11-09 1995-11-03 Small particle formation
BR9509720A BR9509720A (pt) 1994-11-09 1995-11-03 Processo para a preparação de pequenas partículas compreendendo um composto orgânico cuja solubilidade é maior em um primerio solvente miscível em água que em um segundo solvente que é aquoso e uso das pequenas partículas
PT95938091T PT788350E (pt) 1994-11-09 1995-11-03 Formacao de particulas pequenas
AT95938091T ATE213625T1 (de) 1994-11-09 1995-11-03 Herstellung kleiner partikel
JP51597096A JP4098827B2 (ja) 1994-11-09 1995-11-03 微細粒子の形成
DE69525639T DE69525639T2 (de) 1994-11-09 1995-11-03 Herstellung kleiner partikel
CZ971295A CZ129597A3 (en) 1994-11-09 1995-11-03 Process for preparing small particles
DK95938091T DK0788350T3 (da) 1994-11-09 1995-11-03 Dannelse af små partikler
PCT/SE1995/001302 WO1996014833A1 (fr) 1994-11-09 1995-11-03 Formation de petites particules
ES95938091T ES2173204T3 (es) 1994-11-09 1995-11-03 Formacion de particulas pequeñas.
EP95938091A EP0788350B1 (fr) 1994-11-09 1995-11-03 Formation de petites particules
HU9800181A HUT77629A (hu) 1994-11-09 1995-11-03 Eljárás kis részecskék előállítására
KR1019970703072A KR970706799A (ko) 1994-11-09 1995-11-03 소립자 형성(Small Partical Formation)
US08/553,460 US5780062A (en) 1994-11-09 1995-11-03 Small particle formation
PL95320425A PL320425A1 (en) 1994-11-09 1995-11-03 Method of producing small particles
EE9700214A EE9700214A (et) 1994-11-09 1995-11-03 Väikeste osakeste moodustamine
AU38851/95A AU700644B2 (en) 1994-11-09 1995-11-03 Small particle formation
NZ295497A NZ295497A (en) 1994-11-09 1995-11-03 Process for producing small organic particles
ZA959386A ZA959386B (en) 1994-11-09 1995-11-06 Small particle formation
IL11587895A IL115878A0 (en) 1994-11-09 1995-11-06 Small particle formation
TR95/01400A TR199501400A2 (tr) 1994-11-09 1995-11-09 Kücük partikül meydana getirilmesi
IS4467A IS4467A (is) 1994-11-09 1997-04-21 Myndun smárra agna
NO971986A NO971986L (no) 1994-11-09 1997-04-29 Fremgangsmåte for fremstilling av små partikler
FI971947A FI118511B (fi) 1994-11-09 1997-05-07 Pienten partikkelien muodostuminen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403846A SE9403846D0 (sv) 1994-11-09 1994-11-09 Small particle formation

Publications (1)

Publication Number Publication Date
SE9403846D0 true SE9403846D0 (sv) 1994-11-09

Family

ID=20395907

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403846A SE9403846D0 (sv) 1994-11-09 1994-11-09 Small particle formation

Country Status (27)

Country Link
US (1) US5780062A (fr)
EP (1) EP0788350B1 (fr)
JP (1) JP4098827B2 (fr)
KR (1) KR970706799A (fr)
CN (1) CN1165478A (fr)
AT (1) ATE213625T1 (fr)
AU (1) AU700644B2 (fr)
BR (1) BR9509720A (fr)
CA (1) CA2203512A1 (fr)
CZ (1) CZ129597A3 (fr)
DE (1) DE69525639T2 (fr)
DK (1) DK0788350T3 (fr)
EE (1) EE9700214A (fr)
ES (1) ES2173204T3 (fr)
FI (1) FI118511B (fr)
HU (1) HUT77629A (fr)
IL (1) IL115878A0 (fr)
IS (1) IS4467A (fr)
NO (1) NO971986L (fr)
NZ (1) NZ295497A (fr)
PL (1) PL320425A1 (fr)
PT (1) PT788350E (fr)
SE (1) SE9403846D0 (fr)
SK (1) SK55997A3 (fr)
TR (1) TR199501400A2 (fr)
WO (1) WO1996014833A1 (fr)
ZA (1) ZA959386B (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
US7029700B2 (en) * 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
AU2001231000A1 (en) 2000-01-19 2001-07-31 Pharmaceutical Discovery Corporation Dry powder formulations of antihistamine for nasal administration
BR0116377A (pt) * 2000-12-22 2005-12-13 Baxter Int Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US6607784B2 (en) 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6623761B2 (en) 2000-12-22 2003-09-23 Hassan Emadeldin M. Method of making nanoparticles of substantially water insoluble materials
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10117049A1 (de) * 2001-04-05 2002-10-17 Novartis Ag Zusammensetzung
WO2003000226A2 (fr) * 2001-06-22 2003-01-03 Pfizer Products Inc. Compositions pharmaceutiques contenant des ensembles polymere et medicament
DE60220923T2 (de) * 2001-08-06 2008-03-06 Astrazeneca Ab Wässrige dispersion stabiler nanopartikel eines wasserunlöslichen wirkstoffs und ein hilfsstoff wie mittelkettige triglyceride (mct)
EP1423175B1 (fr) * 2001-08-08 2013-10-02 Brown University Research Foundation Procedes de micronisation de medicaments hydrophobes
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
WO2003026611A2 (fr) 2001-09-26 2003-04-03 Baxter International Inc. Preparation de nanoparticules submicroniques par dispersion et elimination d'un solvant ou d'une phase liquide
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US20040028747A1 (en) * 2002-08-06 2004-02-12 Tucker Christopher J. Crystalline drug particles prepared using a controlled precipitation process
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7511079B2 (en) * 2003-03-24 2009-03-31 Baxter International Inc. Methods and apparatuses for the comminution and stabilization of small particles
WO2004103348A2 (fr) * 2003-05-19 2004-12-02 Baxter International Inc. Preparations pharmaceutiques de petites particules d'anticonvulsivants et d'agents contre la demence et agents immmunosupresseurs
JP2006527770A (ja) * 2003-06-18 2006-12-07 アストラゼネカ アクチボラグ Ｃｂ１モジュレーターとしての２−置換５，６−ジアリール−ピラジン誘導体
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
EP1663158A2 (fr) * 2003-06-24 2006-06-07 Baxter International Inc. Methode d'administration de medicaments au cerveau
US8986736B2 (en) * 2003-06-24 2015-03-24 Baxter International Inc. Method for delivering particulate drugs to tissues
EP1663321B1 (fr) 2003-09-22 2012-08-29 Baxter International Inc. Sterilisation a pression elevee afin de steriliser definitivement des preparations pharmaceutiques et des produits medicaux
EP1675571A2 (fr) * 2003-09-30 2006-07-05 Spherics, Inc. Agents therapeutiques nanoparticulaires biologiquement actifs
DE10351087A1 (de) * 2003-10-31 2005-05-25 Bayer Technology Services Gmbh Feste Wirkstoff-Formulierung
CN1913871A (zh) * 2004-01-29 2007-02-14 巴克斯特国际公司 用于提高中枢神经系统投递的抗－逆转录病毒药剂的纳米悬浮液
WO2005077337A2 (fr) * 2004-02-05 2005-08-25 Baxter International Inc. Dispersions preparees avec des agents autostabilisants
BRPI0510271A (pt) * 2004-06-15 2007-10-30 Baxter Int aplicações ex-vivo agentes terapêuticos microparticulados
US20080171687A1 (en) * 2004-09-16 2008-07-17 Abraxis Bioscience, Inc. Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
WO2008135828A2 (fr) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticules comprenant un médicament, de l'éthylcellulose et un sel biliaire
WO2008135855A2 (fr) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticules contenant un inhibiteur de la protéine de transfert d'ester de cholestéryle et un polymère non ionisable
US8530463B2 (en) * 2007-05-07 2013-09-10 Hale Biopharma Ventures Llc Multimodal particulate formulations
JP2010526822A (ja) * 2007-05-07 2010-08-05 クエスター ファーマシューティカルズ，インク． ベンゾジアゼピン類の経鼻投与
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
EP2162120B1 (fr) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticules comportant un polymère cellulosique non ionisable et un copolymère bloc amphiphile non ionisable
WO2008149230A2 (fr) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticules comprenant un médicament, un polymère cellulosique non ionisable et du tocophéryl polyéthylène glycol succinate
US8101274B2 (en) * 2007-06-11 2012-01-24 Spedden Richard H Solid state membranes with surface-embedded glycosylated amphiphilic molecules and micelles formed therefrom
GB0714223D0 (en) * 2007-07-20 2007-08-29 Fujifilm Mfg Europe Bv Preparation of fine particles
US9724362B2 (en) 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2009073216A1 (fr) 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticules comprenant un polymère non ionisable et un copolymère de méthacrylate fonctionnalisé par amine
BRPI0909780B1 (pt) 2008-03-05 2022-05-03 Baxter International Inc Suspensão contendo uma partícula com superfície modificada, composição farmacêutica compreendendo a referida suspensão, método para aprimorar a absorção celular de um agente ativo, uso de partículas com superfície modificada, e método de preparação de uma partícula com superfície modificada
AU2009228093B2 (en) 2008-03-28 2014-08-07 Neurelis, Inc. Administration of benzodiazepine compositions
CN101278921B (zh) * 2008-06-03 2010-06-09 海南百那医药发展有限公司 盐酸托烷司琼微囊及其注射剂生产方法
US20100151037A1 (en) * 2008-08-07 2010-06-17 Yivan Jiang Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
US8889168B2 (en) 2008-08-07 2014-11-18 Bioactive Surgical Inc. Stem cell capture and immobilization coatings for medical devices and implants
US10952965B2 (en) * 2009-05-15 2021-03-23 Baxter International Inc. Compositions and methods for drug delivery
CN102784103A (zh) * 2011-05-16 2012-11-21 中国科学院上海药物研究所 一种通过混合胶束技术制备的普罗布考纳米混悬液及其制备方法
WO2012170866A1 (fr) * 2011-06-10 2012-12-13 Norac Pharma Procédé pour microparticules de peroxyde de benzoyle
PT3415139T (pt) 2011-06-14 2022-06-20 Neurelis Inc Administração de benzodiazepina
WO2015071841A1 (fr) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes de dabigatran et ses dérivés, procédé de préparation de ceux-ci et compositions pharmaceutiques contenant ceux-ci
US20180155290A1 (en) * 2015-05-08 2018-06-07 Davuluri Ramamohan Rao Improved Process for the Preparation of Aripiprazole with Reduced Particle Size

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
CA1282405C (fr) * 1984-05-21 1991-04-02 Michael R. Violante Methode pour produire des particules dimensionnellement uniformes a partir des composes organiques insolubles dans l'eau
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4606940A (en) * 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.

Also Published As

Publication number Publication date
ATE213625T1 (de) 2002-03-15
NO971986D0 (no) 1997-04-29
BR9509720A (pt) 1997-10-21
EE9700214A (et) 1998-04-15
DK0788350T3 (da) 2002-04-29
EP0788350B1 (fr) 2002-02-27
CA2203512A1 (fr) 1996-05-23
FI971947A0 (fi) 1997-05-07
JP4098827B2 (ja) 2008-06-11
EP0788350A1 (fr) 1997-08-13
CZ129597A3 (en) 1997-12-17
PT788350E (pt) 2002-07-31
IL115878A0 (en) 1996-01-31
ES2173204T3 (es) 2002-10-16
DE69525639D1 (de) 2002-04-04
KR970706799A (ko) 1997-12-01
WO1996014833A1 (fr) 1996-05-23
JPH10508840A (ja) 1998-09-02
PL320425A1 (en) 1997-09-29
NZ295497A (en) 1998-05-27
AU700644B2 (en) 1999-01-14
TR199501400A2 (tr) 1996-06-21
AU3885195A (en) 1996-06-06
DE69525639T2 (de) 2002-08-29
US5780062A (en) 1998-07-14
ZA959386B (en) 1996-05-09
NO971986L (no) 1997-04-29
IS4467A (is) 1997-04-21
FI971947L (fi) 1997-05-07
CN1165478A (zh) 1997-11-19
HUT77629A (hu) 1998-06-29
FI118511B (fi) 2007-12-14
SK55997A3 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
SE9403846D0 (sv) Small particle formation
BR9509404A (pt) Composição contendo aerogel processo para sua preparação assim como seu emprego
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
YU49279B (sh) Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenu
ATE390414T1 (de) Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
MX9800867A (es) Halogenobencimidazoles y su empleo como microbicidas.
AU3202595A (en) 1,2-substituted imidazolyl compounds for the treatment of inflammation
FI970147A0 (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
FR2689127B1 (fr) Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
ATE170194T1 (de) Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen
FR2663328B1 (fr) Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
AR245591A1 (es) Una composicion oral estable, con propiedades antiplaca y antigingivales mejoradas.
CA2388325A1 (fr) Composition pharmaceutique aqueuse a base de ciclesonide
DE69332640D1 (de) Pharmazeutische pyridin-derivate
FI925445A0 (fi) Foerfarande foer framstaellning av 10b-h-steroider
DE69526519D1 (de) Silylierungsprocess
ATE259817T1 (de) Herstellung von einem clavulansäuresalz
OA09522A (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer process for the preparation thereof and pharmaceutical compositions containing the same
EP0338793A3 (fr) Sulfonanilides antihypertensifs
MY102055A (en) Small particle formation
JPS6442422A (en) Antiulcer agent
EP1132368A3 (fr) Procédé pour la préparation de chlorure de 2-fluoro-1,1-dichloro-acryloyle